Tuncel A, Pan C, Clem J, Liu D, Qi Y
Nat Rev Mol Cell Biol. 2025; .
PMID: 40055491
DOI: 10.1038/s41580-025-00834-3.
Yee B, Ali N, Mohd-Naim N, Ahmed M
Chem Bio Eng. 2025; 1(4):330-339.
PMID: 39974464
PMC: 11835143.
DOI: 10.1021/cbe.3c00112.
Zheng W, Li H, Liu M, Wei Y, Liu B, Li Z
Signal Transduct Target Ther. 2025; 10(1):66.
PMID: 39955288
PMC: 11830025.
DOI: 10.1038/s41392-025-02147-5.
Chepurna O, Chatterjee A, Li Y, Ding H, Murali R, Black K
Polymers (Basel). 2025; 17(3).
PMID: 39940619
PMC: 11820846.
DOI: 10.3390/polym17030417.
Nayfach S, Bhatnagar A, Novichkov A, Estevam G, Kim N, Hill E
bioRxiv. 2025; .
PMID: 39829748
PMC: 11741284.
DOI: 10.1101/2025.01.06.631536.
Robust genome editing activity and the applications of enhanced miniature CRISPR-Cas12f1.
Park S, Ju S, Jung W, Jeong T, Yoon D, Lee J
Nat Commun. 2025; 16(1):677.
PMID: 39809780
PMC: 11733285.
DOI: 10.1038/s41467-025-56048-w.
Research Progress on the Mechanism and Application of the Type I CRISPR-Cas System.
Yang P, Zhang S, Hu D, Li X, Guo Y, Guo H
Int J Mol Sci. 2024; 25(23).
PMID: 39684256
PMC: 11640852.
DOI: 10.3390/ijms252312544.
Biology and applications of CRISPR-Cas12 and transposon-associated homologs.
Wu W, Adiego-Perez B, van der Oost J
Nat Biotechnol. 2024; 42(12):1807-1821.
PMID: 39633151
DOI: 10.1038/s41587-024-02485-9.
Recent Advances in the CRISPR/Cas-Based Nucleic Acid Biosensor for Food Analysis: A Review.
Sun Y, Wen T, Zhang P, Wang M, Xu Y
Foods. 2024; 13(20).
PMID: 39456285
PMC: 11507162.
DOI: 10.3390/foods13203222.
Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system.
Wang L, Han H
Heliyon. 2024; 10(19):e38588.
PMID: 39397905
PMC: 11471210.
DOI: 10.1016/j.heliyon.2024.e38588.
One-tube detection of Typhimurium using LAMP and CRISPR-Cas12b.
Gong J, Jiang Y, Zhang D, Li T, Fu L, Dou X
Microbiol Spectr. 2024; 12(10):e0127124.
PMID: 39189759
PMC: 11448145.
DOI: 10.1128/spectrum.01271-24.
An accurate and convenient method for via one-step LAMP-CRISPR/Cas12b detection platform.
Liu T, Liu Q, Chen F, Shi Y, Maimaiti G, Yang Z
Front Cell Infect Microbiol. 2024; 14:1409078.
PMID: 39176261
PMC: 11338869.
DOI: 10.3389/fcimb.2024.1409078.
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing.
Lau C, Liang Q, Zhu H
Transgenic Res. 2024; 33(5):323-357.
PMID: 39158822
DOI: 10.1007/s11248-024-00404-x.
CRISPR technology in human diseases.
Feng Q, Li Q, Zhou H, Wang Z, Lin C, Jiang Z
MedComm (2020). 2024; 5(8):e672.
PMID: 39081515
PMC: 11286548.
DOI: 10.1002/mco2.672.
Characterization of NiCas12b for In Vivo Genome Editing.
Zhang Y, Wei J, Wang H, Wang Y
Adv Sci (Weinh). 2024; 11(36):e2400469.
PMID: 39076074
PMC: 11423069.
DOI: 10.1002/advs.202400469.
Light-activated CRISPR-Cas12a for amplified imaging of microRNA in cell cycle phases at single-cell levels.
Liu H, Dong J, Duan Z, Xia F, Willner I, Huang F
Sci Adv. 2024; 10(30):eadp6166.
PMID: 39047109
PMC: 11268419.
DOI: 10.1126/sciadv.adp6166.
Advanced gene therapy system for the treatment of solid tumour: A review.
Ma Y, Liao J, Cheng H, Yang Q, Yang H
Mater Today Bio. 2024; 27:101138.
PMID: 39027677
PMC: 11255123.
DOI: 10.1016/j.mtbio.2024.101138.
TracrRNA reprogramming enables direct PAM-independent detection of RNA with diverse DNA-targeting Cas12 nucleases.
Jiao C, Peeck N, Yu J, Ghaem Maghami M, Kono S, Collias D
Nat Commun. 2024; 15(1):5909.
PMID: 39003282
PMC: 11246509.
DOI: 10.1038/s41467-024-50243-x.
Antagonistic conflict between transposon-encoded introns and guide RNAs.
Zedaveinyte R, Meers C, Le H, Mortman E, Tang S, Lampe G
Science. 2024; 385(6705):eadm8189.
PMID: 38991068
PMC: 11758368.
DOI: 10.1126/science.adm8189.
Engineering miniature IscB nickase for robust base editing with broad targeting range.
Han L, Hu Y, Mo Q, Yang H, Gu F, Bai F
Nat Chem Biol. 2024; 20(12):1629-1639.
PMID: 38977788
DOI: 10.1038/s41589-024-01670-w.